A false positive STD test happens when a screening test reads positive even though you don't actually have the infection. It's uncommon with modern testing, and it's why HIV and syphilis use a two-step process: an initial screen followed by a different confirmatory test. A single reactive screen isn't a diagnosis until that second step agrees.
| Item | Days after exposure |
|---|---|
| Chlamydia / gonorrhea (NAAT) | ~14 |
| HIV — NAT | 10–33 |
| HIV — antigen/antibody | 18–45 |
| HIV — rapid antibody | 23–90 |
What a "positive" result actually means
A positive (or "reactive") result means the test detected something it's designed to flag — the genetic material of a bacterium, or antibodies your immune system made in response to an infection. With the most sensitive tests, that signal usually reflects a real infection. But a "reactive" first-line screen and a diagnosis are not the same thing, and for some infections they're deliberately kept separate.
How likely a single positive is to be wrong depends on three things: how good the test is, what type of test it is, and how common the infection is in people like you. A screening test run in a low-risk person with no exposure history is more likely to throw an occasional false alarm than the same test run after a known exposure. Two-step confirmation exists to handle that math.
How accurate STD tests are
For chlamydia and gonorrhea, the standard is a NAAT — a nucleic acid amplification test that copies and detects the organism's DNA or RNA. NAATs are the most sensitive method available, which is why both the CDC and USPSTF recommend them, and modern versions are highly accurate, with specificity around 99% USPSTF screening. High specificity means very few people without the infection test positive. But "very few" isn't zero, so a surprising result still deserves scrutiny.
The sample is simple: a urine cup or a self-collected swab for chlamydia, gonorrhea, and trichomoniasis, and a blood draw for HIV, syphilis, and hepatitis. Trichomoniasis is also tested by NAAT CDC chlamydia guidance.
The two-step process for HIV and syphilis
HIV and syphilis are the two infections where false-positive concern is built into the workflow. Both use an initial screening test, then a different confirmatory test, and the result isn't final until the confirmatory step agrees CDC HIV testing. A reactive rapid HIV test, in particular, is a preliminary result that must be confirmed with a follow-up lab test before anyone calls it a diagnosis. It's a reason to confirm, nothing more.
Syphilis testing reads antibodies, and antibody tests are where most cross-reactive false positives come from. Conditions like pregnancy, certain autoimmune diseases (such as lupus), other infections, and older age can produce a reactive screening result that the confirmatory test then sorts out, since the two tests work on different principles CDC syphilis lab 2024. A so-called "biologic false positive" on the first syphilis test is a known, well-described event that the confirmatory step catches.
Herpes IgM antibody testing deserves a specific warning. IgM tests are notorious for false positives and don't reliably distinguish a new infection from an old one or even from a related virus. Most experts advise against routine IgM herpes testing for this reason. If herpes testing is on the table, type-specific antibody testing or testing a sore directly is the more dependable route — ask which test was run before you trust an IgM result.
False positives, false negatives, and the window period
A false negative is the mirror image, and it's actually the more common pitfall. The single biggest cause is testing before the window period is over — the stretch between exposure and when a test can detect the infection. Test too early and the result reads negative because the infection isn't detectable yet, not because the test failed. Repeat a too-early negative; the timing was off, not the test.
For HIV, the window depends on the test type: a nucleic acid test (NAT) can detect infection about 10–33 days after exposure, an antigen/antibody lab test about 18–45 days, and a rapid antibody test about 23–90 days. For chlamydia and gonorrhea, a NAAT is generally reliable about 2 weeks after exposure; if you tested sooner, retesting later is reasonable when a recent exposure is possible. For the full breakdown by test, see when to test after exposure.
| Scenario | What's going on | What to do |
|---|---|---|
| Reactive rapid HIV screen | Preliminary result, not a diagnosis | Get the confirmatory lab test before concluding anything |
| Positive syphilis screen, feel fine | Possible biologic false positive (pregnancy, autoimmune, other infections) | Wait for the confirmatory test to agree |
| Positive herpes IgM | IgM is unreliable and cross-reactive | Ask for type-specific testing or direct testing of a sore |
| Negative test soon after exposure | Likely too early — window period not over | Retest at the right time |
| Positive chlamydia/gonorrhea NAAT | Very likely real — NAAT specificity ~99% | Start treatment; arrange retesting later |
How long results take
The visit itself is short — a urine cup or self-swab, or a quick blood draw, is minutes in the chair. Results typically come back in a day or a few, depending on the lab and the test. Two-step results for HIV or syphilis can take a little longer because the confirmatory test runs after the screen. A reactive screen isn't an instant verdict; the lab moves to step two.
What to do after a surprising positive
- Don't panic and don't self-diagnose off a single screening result — especially a rapid HIV test or a herpes IgM test, the two most prone to false positives.
- Ask exactly which test was run. "Reactive rapid HIV" and "confirmed positive" are different stages, and so is "IgM positive" versus "type-specific antibody positive."
- For HIV or syphilis, confirm it. A diagnosis isn't final until the confirmatory step agrees.
- For chlamydia or gonorrhea, a positive NAAT is very likely real. These don't use a two-step confirmation because the test is already highly specific, so treatment is reasonable to start.
- Tell your clinician about anything that can cause cross-reactivity: pregnancy, an autoimmune condition, a recent vaccine or other infection.
- If you treated chlamydia or gonorrhea, plan to retest — see chlamydia reinfection for the timing and why retesting matters.
When to see a clinician
See a clinician whenever a result is reactive and you want it interpreted properly, when you have symptoms, or when you have a known exposure and need to time testing correctly. A clinician can order the right confirmatory test, factor in your risk and exposure history, and tell you whether a result is likely a true positive or a quirk worth re-running. You don't need symptoms to get checked. Most STIs cause none, and testing is what tells you your status. See can you get an std test without symptoms? if that's your situation.
Cost shouldn't be the barrier. Testing is available at doctors' offices, health departments, Planned Parenthood, and Title X family-planning clinics — often free or on an income-based sliding scale — and at-home and self-collection kits exist. The US has roughly 16,000 federally-funded community health centers and about 4,200 Title X clinics, plus tens of thousands of other public STI clinics, so you're rarely far from low-cost care HRSA health centers. When you're ready, you can get tested or compare testing providers to find an option that fits — just mind the window period so you test at the right time.